Emami acquires 36.7% in Axiom Ayurveda, makes it subsidiary

Listed Co AcquisitionStrategic Transactions View source PDF

EMAMILTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.8%1-day move

₹390.30

prior close

₹390.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.6-0.4-0.9-0.1+3.8+4.9+7.3+6.7+8.9+8.6+17.5+16.9+0.4+6.7

Up moveDown movePending

AI summary

Emami Limited has entered into a Share Purchase Agreement to acquire ~73.5% stake in Axiom Ayurveda Pvt Ltd (AAPL), where it already held ~26.5% as an associate. In the first tranche on April 1, 2026, Emami bought 84,30,909 equity shares (~36.7%), making AAPL a subsidiary. The remaining ~36.8% stake will be acquired by June 2026 as per the SPA terms.

Likely market impact

Strengthens Emami's Ayurveda portfolio. Subsidiary status enables full operational control, revenue consolidation, and potential margin benefits.